Literature DB >> 7879212

Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.

P J Friend1, P Rebello, D Oliveira, V Manna, S P Cobbold, G Hale, N V Jamieson, I Jamieson, R Y Calne, D T Harris.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7879212

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award.

Authors:  Jillian Hurst
Journal:  J Clin Invest       Date:  2012-10       Impact factor: 14.808

2.  Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Authors:  M G Wing; T Moreau; J Greenwood; R M Smith; G Hale; J Isaacs; H Waldmann; P J Lachmann; A Compston
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  Alemtuzumab induction therapy in solid organ transplantation.

Authors:  Peter J Friend
Journal:  Transplant Res       Date:  2013-11-20

4.  Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.

Authors:  Richard Haynes; Colin Baigent; Paul Harden; Martin Landray; Murat Akyol; Argiris Asderakis; Alex Baxter; Sunil Bhandari; Paramit Chowdhury; Marc Clancy; Jonathan Emberson; Paul Gibbs; Abdul Hammad; Will Herrington; Kathy Jayne; Gareth Jones; Nithya Krishnan; Michael Lay; David Lewis; Iain Macdougall; Chidambaram Nathan; James Neuberger; Chas Newstead; Ravi Pararajasingam; Carmelo Puliatti; Keith Rigg; Peter Rowe; Adnan Sharif; Neil Sheerin; Sanjay Sinha; Chris Watson; Peter Friend
Journal:  Transplant Res       Date:  2013-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.